Stocks
Ono Pharmaceutical Co., Ltd.OPHLY
OTCHealthcarePharmaceuticals$4.88+1.24%
A Japan-based pharmaceutical developer focused on oncology, immunology, and metabolic diseases, with a portfolio that includes both internally developed drugs and licensed therapies. It is widely known for its role in developing the immunotherapy nivolumab (Opdivo) in partnership with Bristol Myers ...
Market Cap: $6.9B52W Range: $3.28 – $5.75
Congressional Interest in Ono Pharmaceutical Co., Ltd. (OPHLY)
1 member of Congress has disclosed 1 trade in Ono Pharmaceutical Co., Ltd. (OPHLY), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
0
Sells
1
Who in Congress Is Trading OPHLY?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-07-10 | Daniel Goldman | sell | $1K – $15K |